Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Lisata Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Lisata Therapeutics

Lisata Therapeutics

Public

Lisata Therapeutics, Inc.: A global biopharmaceutical firm focusing on cardiovascular and autoimmune diseases.

HQ
Basking Ridge, NJ, US
Founded
1980
Overview
Compare
Fundraising
Employees
Website

Lisata Therapeutics, Inc., founded in New York, is a global biopharmaceutical company dedicated to developing innovative therapies for cardiovascular and autoimmune diseases. The company's core mission is to address high unmet medical needs through targeted therapy and rigorous data application. Lisata's product offerings include the CendR Platform® Technology, which enhances the delivery of anti-cancer drugs to solid tumors and targets non-cancerous, immunosuppressive cells, thereby improving treatment efficacy.

Notable figures associated with Lisata Therapeutics include leading scientists and industry experts who contribute to its research and development efforts. The company has attracted significant investment from prominent venture capital firms, underscoring confidence in its potential. Key achievements include advancing multiple clinical-stage therapies and demonstrating promising results in early trials. Lisata's impact is reflected in its commitment to transforming patient outcomes through cutting-edge biopharmaceutical innovations.

Lisata Therapeutics - Similar Companies

Lusaris Therapeutics logo

Lusaris Therapeutics

lusaristx.com

Thetis Pharmaceuticals logo

Thetis Pharmaceuticals

thetispharma.com

Lyst Therapeutics logo

Lyst Therapeutics

Lysosomal Therapeutics logo

Lysosomal Therapeutics

lysosomaltx.com

Celsius Therapeutics logo

Celsius Therapeutics

celsiustx.com

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

Lapix Therapeutics logo

Lapix Therapeutics

lapix.com

LTZ Therapeutics logo

LTZ Therapeutics

LizarBio Therapeutics logo

LizarBio Therapeutics

Rise Therapeutics logo

Rise Therapeutics

Lassen Therapeutics logo

Lassen Therapeutics

MapLight Therapeutics logo

MapLight Therapeutics

Cardurion Pharmaceuticals logo

Cardurion Pharmaceuticals

Cartesian Therapeutics logo

Cartesian Therapeutics

Lyra Therapeutics logo

Lyra Therapeutics

Lisata Therapeutics - Quick Facts

Who are Lisata Therapeutics' competitors?

Companies similar to Lisata Therapeutics include Lusaris Therapeutics, Thetis Pharmaceuticals, Lyst Therapeutics and Lysosomal Therapeutics.

When was Lisata Therapeutics founded?

Lisata Therapeutics was founded in 1980.

Where is Lisata Therapeutics' headquarters located?

Lisata Therapeutics' headquarters is located in Basking Ridge, NJ, US.

When was Lisata Therapeutics' last funding round?

Lisata Therapeutics' most recent funding round was for $1.4M (USD) in May 2021.

How much has Lisata Therapeutics raised to-date?

As of May 12, 2021, Lisata Therapeutics has raised a total of $165.6M (USD).

How many employees does Lisata Therapeutics have?

Lisata Therapeutics has 500 employees as of Feb 6, 2024.

Lisata Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
  • Therapeutics
Tags
  • Biotech
  • Healthtech
Unique IDs
  • ein: 222343568
  • secCik: 0000320017
  • ticker: LSTA
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 25 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 524000Insurance Carriers and Related Activities
  • 524100Insurance Carriers
  • 524120Direct Insurance (except Life, Health, and Medical) Carriers
  • 524128Other Direct Insurance (except Life, Health, and Medical) Carriers
  • 520000Finance and Insurance
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 6300Insurance Carriers
  • 6390Insurance Carriers, Not Elsewhere Classified
  • 6399Insurance carriers, nec
  • 8090Miscellaneous Health And Allied Services, Not Elsewhere Classified
  • 5000Wholesale Trade-durable Goods
  • 6000Depository Institutions
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 6512Non-life insurance